{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:14:37Z","timestamp":1786986877701,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K20715"],"award-info":[{"award-number":["JP22K20715"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K18655"],"award-info":[{"award-number":["25K18655"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020109","name":"Fukuoka Public Health Promotion Organization Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008728","name":"Japan Research Foundation for Clinical Pharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008731","name":"Nakatomi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.clnu.2026.106581","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T17:19:18Z","timestamp":1768929558000},"page":"106581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Prospective study of anamorelin in pancreatic cancer cachexia: Clinical and translational insights into response heterogeneity"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5444-2443","authenticated-orcid":false,"given":"Ryosuke","family":"Matsukane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruna","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keijiro","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Komori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minako","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitose","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimi","family":"Morito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomiko","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayako","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2026.106581_bib1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clnu.2026.106581_bib2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1200\/JCO.2014.56.1894","article-title":"Diagnostic criteria for the classification of cancer-associated weight loss","volume":"33","author":"Martin","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clnu.2026.106581_bib3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.12-5-594","article-title":"Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers","volume":"12","author":"Garcia","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.clnu.2026.106581_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ghir.2008.12.003","article-title":"Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers","volume":"19","author":"Garcia","year":"2009","journal-title":"Growth Hormone IGF Res"},{"key":"10.1016\/j.clnu.2026.106581_bib5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clnu.2026.106581_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/SPC.0000000000000299","article-title":"What is next after anamorelin?","volume":"11","author":"Garcia","year":"2017","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.clnu.2026.106581_bib7","first-page":"3495","article-title":"Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial","volume":"24","author":"Takayama","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clnu.2026.106581_bib8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/cncr.31128","article-title":"Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04)","volume":"124","author":"Katakami","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.clnu.2026.106581_bib9","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1002\/cncr.32406","article-title":"A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia","volume":"125","author":"Hamauchi","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.clnu.2026.106581_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jcsm.12675","article-title":"The regulatory approval of anamorelin for treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers","volume":"12","author":"Wakabayashi","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2026.106581_bib11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1634\/theoncologist.2018-0266","article-title":"Pancreas cancer-associated weight loss","volume":"24","author":"Hendifar","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.clnu.2026.106581_bib12","first-page":"5271","article-title":"Incidence and frequency of cancer cachexia during chemotherapy for advanced pancreatic ductal adenocarcinoma","volume":"28","author":"Mitsunaga","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clnu.2026.106581_bib13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.clnu.2016.12.028","article-title":"Validity of bioelectrical impedance analysis in estimation of fat-free mass in colorectal cancer patients","volume":"37","author":"R\u00e6der","year":"2018","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2026.106581_bib14","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1186\/s12885-018-4904-6","article-title":"Bioelectrical impedance analysis for monitoring cancer patients receiving chemotherapy and home parenteral nutrition","volume":"18","author":"Cotogni","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clnu.2026.106581_bib15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/(SICI)1099-1611(199907\/08)8:4<355::AID-PON401>3.0.CO;2-I","article-title":"Development of quality of life questionnaire in Japan: quality of life assessment of cancer patients receiving chemotherapy","volume":"8","author":"Kurihara","year":"1999","journal-title":"Psychooncology"},{"key":"10.1016\/j.clnu.2026.106581_bib16","first-page":"621","article-title":"Factors associated with early discontinuation of anamorelin in patients with cancer-associated cachexia","volume":"31","author":"Tsukiyama","year":"2023","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clnu.2026.106581_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40780-024-00359-5","article-title":"CONUT score as a predictor for anamorelin efficacy in patients with cancer cachexia receiving chemotherapy","volume":"10","author":"Fujii","year":"2024","journal-title":"J Pharm Health Care Sci"},{"key":"10.1016\/j.clnu.2026.106581_bib18","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clnu.2026.106581_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuropharm.2019.01.001","article-title":"Ghrelin and food reward","volume":"148","author":"Al Massadi","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.clnu.2026.106581_bib20","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/cncr.34154","article-title":"A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index","volume":"128","author":"Naito","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.clnu.2026.106581_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.13732","article-title":"Anamorelin efficacy in non-small-cell lung cancer patients with cachexia: insights from ROMANA 1 and ROMANA 2","volume":"16","author":"Laird","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2026.106581_bib22","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2409515","article-title":"Ponsegromab for the treatment of cancer cachexia","author":"Groarke","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clnu.2026.106581_bib23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2026.106581_bib24","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1002\/jcsm.13323","article-title":"Diagnosis and outcomes of cachexia in Asia: Working consensus report from the Asian working group for cachexia","volume":"14","author":"Arai","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2026.106581_bib25","doi-asserted-by":"crossref","first-page":"9014","DOI":"10.1245\/s10434-025-18264-y","article-title":"Defining low muscle mass in cancer patients: sex-specific computed tomography-derived cutoff values and survival impact-A multicenter cohort study","volume":"32","author":"Yamamoto","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clnu.2026.106581_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.13871","article-title":"A randomized trial of nutrition and exercise treatment in patients with pancreatic and non-small cell lung cancer (NEXTAC-TWO)","volume":"16","author":"Mitsunaga","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2026.106581_bib27","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1111\/1759-7714.14154","article-title":"Challenges in enhancing physical performance in thoracic cancer cachexia","volume":"12","author":"Naito","year":"2021","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.clnu.2026.106581_bib28","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/annonc\/mdx192","article-title":"ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia","volume":"28","author":"Currow","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clnu.2026.106581_bib29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ncpendmet0427","article-title":"Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1","volume":"3","author":"LeRoith","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metabol"},{"key":"10.1016\/j.clnu.2026.106581_bib30","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1159\/000533539","article-title":"Adverse metabolic effects on glucose in patients receiving anamorelin using a Japanese claims database","volume":"101","author":"Ohta","year":"2023","journal-title":"Oncology"},{"key":"10.1016\/j.clnu.2026.106581_bib31","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s10147-024-02546-8","article-title":"The efficacy and safety of anamorelin among patients with diabetes","volume":"29","author":"Ando","year":"2024","journal-title":"Int J Clin Oncol"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561426000087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561426000087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:59:00Z","timestamp":1777532340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561426000087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":31,"alternative-id":["S0261561426000087"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2026.106581","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective study of anamorelin in pancreatic cancer cachexia: Clinical and translational insights into response heterogeneity","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2026.106581","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106581"}}